Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Different oxysterols have opposing actions at N-methyl-D-aspartate receptors.

Linsenbardt AJ, Taylor A, Emnett CM, Doherty JJ, Krishnan K, Covey DF, Paul SM, Zorumski CF, Mennerick S.

Neuropharmacology. 2014 Oct;85:232-42. doi: 10.1016/j.neuropharm.2014.05.027. Epub 2014 May 27.

2.

The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors.

Paul SM, Doherty JJ, Robichaud AJ, Belfort GM, Chow BY, Hammond RS, Crawford DC, Linsenbardt AJ, Shu HJ, Izumi Y, Mennerick SJ, Zorumski CF.

J Neurosci. 2013 Oct 30;33(44):17290-300. doi: 10.1523/JNEUROSCI.2619-13.2013.

3.
4.

Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking.

Lan JY, Skeberdis VA, Jover T, Zheng X, Bennett MV, Zukin RS.

J Neurosci. 2001 Aug 15;21(16):6058-68.

5.

Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.

Subramaniam S, Donevan SD, Rogawski MA.

J Pharmacol Exp Ther. 1996 Jan;276(1):161-8.

PMID:
8558426
6.
7.

Corticosterone acutely prolonged N-methyl-d-aspartate receptor-mediated Ca2+ elevation in cultured rat hippocampal neurons.

Takahashi T, Kimoto T, Tanabe N, Hattori TA, Yasumatsu N, Kawato S.

J Neurochem. 2002 Dec;83(6):1441-51.

8.

Characterization of l-Theanine Excitatory Actions on Hippocampal Neurons: Toward the Generation of Novel N-Methyl-d-aspartate Receptor Modulators Based on Its Backbone.

Sebih F, Rousset M, Bellahouel S, Rolland M, de Jesus Ferreira MC, Guiramand J, Cohen-Solal C, Barbanel G, Cens T, Abouazza M, Tassou A, Gratuze M, Meusnier C, Charnet P, Vignes M, Rolland V.

ACS Chem Neurosci. 2017 Aug 16;8(8):1724-1734. doi: 10.1021/acschemneuro.7b00036. Epub 2017 May 30.

PMID:
28511005
9.

Calcium-induced inactivation of NMDA receptor-channels evolves independently of run-down in cultured rat brain neurones.

Medina I, Filippova N, Bakhramov A, Bregestovski P.

J Physiol. 1996 Sep 1;495 ( Pt 2):411-27.

11.

Pathologically activated neuroprotection via uncompetitive blockade of N-methyl-D-aspartate receptors with fast off-rate by novel multifunctional dimer bis(propyl)-cognitin.

Luo J, Li W, Zhao Y, Fu H, Ma DL, Tang J, Li C, Peoples RW, Li F, Wang Q, Huang P, Xia J, Pang Y, Han Y.

J Biol Chem. 2010 Jun 25;285(26):19947-58. doi: 10.1074/jbc.M110.111286. Epub 2010 Apr 19.

12.

Different structural requirements for functional ion pore transplantation suggest different gating mechanisms of NMDA and kainate receptors.

Villmann C, Hoffmann J, Werner M, Kott S, Strutz-Seebohm N, Nilsson T, Hollmann M.

J Neurochem. 2008 Oct;107(2):453-65. doi: 10.1111/j.1471-4159.2008.05623.x. Epub 2008 Aug 14.

14.

Memantine selectively blocks extrasynaptic NMDA receptors in rat substantia nigra dopamine neurons.

Wu YN, Johnson SW.

Brain Res. 2015 Apr 7;1603:1-7. doi: 10.1016/j.brainres.2015.01.041. Epub 2015 Feb 2.

PMID:
25656790
15.

Protein kinase C modulates NMDA receptor trafficking and gating.

Lan JY, Skeberdis VA, Jover T, Grooms SY, Lin Y, Araneda RC, Zheng X, Bennett MV, Zukin RS.

Nat Neurosci. 2001 Apr;4(4):382-90.

PMID:
11276228
16.

Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit.

Matteucci A, Cammarota R, Paradisi S, Varano M, Balduzzi M, Leo L, Bellenchi GC, De Nuccio C, Carnovale-Scalzo G, Scorcia G, Frank C, Mallozzi C, Di Stasi AM, Visentin S, Malchiodi-Albedi F.

Invest Ophthalmol Vis Sci. 2011 Feb 22;52(2):1070-7. doi: 10.1167/iovs.10-5966.

PMID:
20861489
17.

Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies.

Liu YW, Luo JL, Ren H, Peoples RW, Ai YX, Liu LJ, Pang YP, Li ZW, Han YF, Li CY.

Neuropharmacology. 2008 Jun;54(7):1086-94. doi: 10.1016/j.neuropharm.2008.02.015. Epub 2008 Mar 2.

PMID:
18407299
18.
19.

Interleukin-2 modulates N-methyl-D-aspartate receptors of native mesolimbic neurons.

Ye JH, Tao L, Zalcman SS.

Brain Res. 2001 Mar 16;894(2):241-8.

PMID:
11251197
20.

Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.

Emnett CM, Eisenman LN, Mohan J, Taylor AA, Doherty JJ, Paul SM, Zorumski CF, Mennerick S.

Br J Pharmacol. 2015 Mar;172(5):1333-47. doi: 10.1111/bph.13007. Epub 2015 Jan 13.

Supplemental Content

Support Center